Idiopathic inflammatory myopathy associated with malignancy: A retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis

Journal of Rheumatology

Volumn 38, Issue 11, 2011, Pages 2432-2435

  So, Min Wook ^a   Koo, Bon San ^a   Kim, Yong Gil ^a   Lee, Chang Keun ^a   Yoo, Bin ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Dermatomyositis; Neoplasms; Polymyositis; Risk

Indexed keywords

ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASE;

ADULT; AGE; ARTICLE; BILE DUCT CANCER; BREAST CANCER; CLINICAL FEATURE; COHORT ANALYSIS; COLON CANCER; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DERMATOMYOSITIS; DISEASE ASSOCIATION; DYSPHAGIA; ETHNIC GROUP; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; KOREAN; LABORATORY TEST; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIVARIATE ANALYSIS; NASOPHARYNX CANCER; NONHODGKIN LYMPHOMA; OVARY CANCER; PANCREAS CANCER; POLYMYOSITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STANDARDIZED INCIDENCE RATIO; STOMACH CANCER; THYROID CANCER; UNIVARIATE ANALYSIS;

ADULT; AGE FACTORS; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; COMORBIDITY; DEGLUTITION DISORDERS; DERMATOMYOSITIS; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMYOSITIS; PREVALENCE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 80155181457     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110320     Document Type: Article

References (21)

1. Stertz G. Polymyositis. Berl Klin Wochenschr 1916;53:489.
2. Sigurgeirsson B, Lindelof B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 1992;326:363-7.
3. Buchbinder R, Forbes A, Hall S, Dennett X, Giles G. Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med 2001;134:1087-95.
4. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of 2 parts). N Engl J Med 1975;292:344-7.
5. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001;357:96-100. (Pubitemid 32094911)
6. Stockton D, Doherty VR, Brewster DH. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 2001;85:41-5. (Pubitemid 32695714)
7. Wakata N, Kurihara T, Saito E, Kinoshita M. Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study. Int J Dermatol 2002;41:729-34. (Pubitemid 35422835)
8. Chinoy H, Fertig N, Oddis CV, Ollier WE, Cooper RG. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis 2007;66:1345-9. (Pubitemid 47492479)
9. Huang YL, Chen YJ, Lin MW, Wu CY, Liu PC, Chen TJ, et al. Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study. Br J Dermatol 2009;161:854-60.
10. Hunger RE, Durr C, Brand CU. Cutaneous leukocytoclastic vasculitis in dermatomyositis suggests malignancy. Dermatology 2001;202:123-6. (Pubitemid 32337162)
11. Fardet L, Dupuy A, Gain M, Kettaneh A, Cherin P, Bachelez H, et al. Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis. Medicine 2009;88:91-7.
12. Basset-Seguin N, Roujeau JC, Gherardi R, Guillaume JC, Revuz J, Touraine R. Prognostic factors and predictive signs of malignancy in adult dermatomyositis. A study of 32 cases. Arch Dermatol 1990;126:633-7. (Pubitemid 20157677)
13. Airio A, Pukkala E, Isomaki H. Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol 1995;22:1300-3.
14. Antiochos BB, Brown LA, Li Z, Tosteson TD, Wortmann RL, Rigby WF. Malignancy is associated with dermatomyositis but not polymyositis in Northern New England, USA. J Rheumatol 2009;36:2704-10.
15. Hochberg MC, Feldman D, Stevens MB. Adult onset polymyositis/ dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature. Semin Arthritis Rheum 1986;15:168-78. (Pubitemid 16132225)
16. Chen YJ, Wu CY, Shen JL. Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study. Br J Dermatol 2001;144:825-31.
17. Chen YJ, Wu CY, Huang YL, Wang CB, Shen JL, Chang YT. Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan. Arthritis Res Ther 2010;12:R70.
18. Andras C, Ponyi A, Constantin T, Csiki Z, Szekanecz E, Szodoray P, et al. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol 2008;35:438-44. (Pubitemid 351374417)
19. Ponyi A, Constantin T, Garami M, Andras C, Tallai B, Vancsa A, et al. Cancer-associated myositis: clinical features and prognostic signs. Ann NY Acad Sci 2005;1051:64-71. (Pubitemid 41362733)
20. Azuma K, Yamada H, Ohkubo M, Yamasaki Y, Yamasaki M, Mizushima M, et al. Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis. Mod Rheumatol 2011;21:178-83.
21. Maugars YM, Berthelot JM, Abbas AA, Mussini JM, Nguyen JM, Prost AM. Long-term prognosis of 69 patients with dermatomyositis or polymyositis. Clin Exp Rheumatol 1996;14:263-74. (Pubitemid 26290866)